On Completion. (a) the Institutional Investors (as set out in Schedule 1) other than Novartis shall subscribe in cash for and shall be issued the number of Ordinary Shares set opposite their name in column 3 of Part A of Schedule 1 for the price specified in column 4 of Part A of Schedule 1; and
Appears in 6 contracts
Samples: Bct197 Asset Purchase Agreement (Mereo Biopharma Group PLC), Bgs649 Asset Purchase Agreement (Mereo Biopharma Group PLC), Bgs649 Asset Purchase Agreement (Mereo Biopharma Group PLC)
On Completion. (a) the Institutional Investors (as set out in Schedule 1) other than Novartis shall subscribe in cash for and shall be issued the number of Ordinary Shares set opposite their name in column 3 of Part A of Schedule 1 for the price specified in column 4 of Part A of Schedule 1; andand [***] Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission. Confidential Treatment has been requested with respect to the omitted portions.
Appears in 3 contracts
Samples: Bps804 Asset Purchase Agreement (Mereo Biopharma Group PLC), Bps804 Asset Purchase Agreement (Mereo Biopharma Group PLC), Bps804 Asset Purchase Agreement (Mereo Biopharma Group PLC)